Qutenza 179 mg cutaneous patch, CAPSAICIN, Qutenza 179 mg cutaneous patch clinical trials

An interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial evaluating the efficacy and safety of Qutenza® in subjects with post-surgical neuropathic pain

This study is looking at how well a patch called Qutenza works for nerve pain after surgery. It compares Qutenza to a dummy patch to see if it reduces pain and is safe for people 18 and over.